Abstract Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has
affected nearly 600 million people to date across the world. While COVID-19 is primarily a …

Myocarditis is defined as a non-ischemic inflammatory disease of the myocardium. It
remains a challenge to diagnose given non-specific symptoms and lack of specific blood …

Background Data on medium-term outcomes in indivduals with myocarditis after mRNA
COVID-19 vaccination are scarce. We aimed to assess clinical outcomes and quality of life …

The development of messenger RNA (mRNA) COVID-19 vaccines is a remarkable biotech
story. While traditional vaccines took 5-10 years to develop, the COVID-19 vaccines took …

COVID-19 is associated with acute and longer-term cardiovascular manifestations including
myocardial injury, myopericarditis, stress-induced cardiomyopathy, myocardial infarction …

The development of safe and effective vaccines against severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2) was a major turning point in the fight against the Coronavirus …

Vaccines have had a tremendous impact on reducing the burden of infectious diseases;
however, they have the potential to cause adverse events following immunization (AEFIs) …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
revealed several cardiovascular complications, including myocarditis caused by SARS-CoV …

Globally, over 650 million people have had COVID‐19 due to infection with the SARS‐Cov‐
2 virus. Cardiac complications in the acute infectious and early recovery phase were …

Background Mass COVID-19 vaccination campaigns have helped impede the COVID-19
pandemic. In rare cases, some vaccines have led to vaccine associated myocarditis in a …